US Food and Drug Administration inspectors only had about a month to resume in-person inspections in India before a surge of coronavirus infections forced their suspension once again.
Drug-related inspections restarted in February following nearly a year-long pause due to the safety and travel restrictions necessitated by the global pandemic
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?